Osaka, Japan

Toshio Nishihara



 

Average Co-Inventor Count = 3.6

ph-index = 5

Forward Citations = 70(Granted Patents)


Location History:

  • Nishinomiya, JP (1998 - 2005)
  • Osaka, JP (1997 - 2023)

Company Filing History:


Years Active: 1997-2023

Loading Chart...
Loading Chart...
Loading Chart...
13 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Toshio Nishihara

Introduction

Toshio Nishihara, a prominent inventor based in Osaka, Japan, has made significant strides in the field of cancer immunotherapy. With a total of 13 patents to his name, his work is characterized by groundbreaking innovations aimed at enhancing cancer treatment methodologies.

Latest Patents

Among his latest patents is the development of the WT1 antigen peptide conjugate vaccine. This novel compound is designed with a complex formula involving MHC class I-restricted peptides that are critical in targeting cancer cells. His vaccine incorporates various cancer antigen peptides, ensuring versatility in treatment approaches. Another pivotal patent is the method for cancer immunotherapy, which presents a unique compound with potential applications in therapeutics, focusing on activating the body’s immune response against cancer.

Career Highlights

Toshio Nishihara's career includes significant positions at esteemed organizations such as the International Institute of Cancer Immunology and Sumitomo Pharmaceuticals Company Limited. His contributions in these roles have propelled advancements in immunotherapeutic strategies, positioning him as a vital figure in cancer research.

Collaborations

Throughout his career, Nishihara has collaborated with notable professionals in the field, including Masashi Gotoh and Yasuyuki Ueki. These partnerships have fostered an environment of innovation and mutual growth, driving forward the mission to improve cancer treatments through scientific research and collaboration.

Conclusion

In conclusion, Toshio Nishihara stands out as a dedicated inventor whose innovations are paving the way for more effective cancer immunotherapy. His extensive work, evidenced by numerous patents, highlights his commitment to enhancing health outcomes for patients battling cancer. His contributions continue to inspire ongoing research and development in the medical field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…